Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Pratik S. Multani, MD
ORIC Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Cancer Research Center/university Health Network
Toronto, Ontario, Canada
- James R. Berenson, Md, Inc.
West Hollywood, California, United States
- Northside Hospital Cancer Institute
Atlanta, Georgia, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Mayo Clinical Rochester
Rochester, Minnesota, United States
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- the Charlotte-Mecklenburg Hospital Authority D/b/a Atrium Health
Charlotte, North Carolina, United States
- Swedish Health Services
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jan 2022
- Primary completion
- 3 Mar 2025
- Completion
- 3 Mar 2025
- Last update posted
- 20 Mar 2025
- Registered enrollment
- 31
- Registry id
- NCT05227144
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.